Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study

Background: Boosted protease inhibitors (PIs), including ritonavir-boosted atazanavir (ATV/r), are a recommended option for the initial treatment of HIV-1 infection based upon clinical trial data; however, long-term real-life clinical data are limited. Objective: We evaluated the long-term use of AT...

Descripción completa

Detalles Bibliográficos
Autores principales: Teófilo, Eugénio, Rocha-Pereira, Nuno, Kuhlmann, Birger, Antela, Antonio, Knechten, Heribert, Santos, Jesús, Jiménez-Expósito, Maria Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975100/
https://www.ncbi.nlm.nih.gov/pubmed/26899539
http://dx.doi.org/10.1080/15284336.2015.1112494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975100/
https://www.ncbi.nlm.nih.gov/pubmed/26899539
http://dx.doi.org/10.1080/15284336.2015.1112494

Ejemplares similares